AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 285 filers reported holding AMEDISYS INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,820,531 | -40.1% | 215,099 | -32.0% | 0.03% | -43.3% |
| Q4 2022 | $26,424,204 | -51.9% | 316,306 | -44.3% | 0.06% | -56.2% |
| Q3 2022 | $54,986,000 | -8.6% | 568,107 | -0.8% | 0.14% | -4.2% |
| Q2 2022 | $60,190,000 | +62.5% | 572,598 | +166.3% | 0.14% | +90.7% |
| Q1 2022 | $37,042,000 | -10.0% | 215,000 | -15.4% | 0.08% | -5.1% |
| Q4 2021 | $41,160,000 | +1.7% | 254,258 | -6.3% | 0.08% | -6.0% |
| Q3 2021 | $40,471,000 | +1.9% | 271,442 | +67.3% | 0.08% | +5.0% |
| Q2 2021 | $39,733,000 | +103.2% | 162,224 | +119.7% | 0.08% | +90.5% |
| Q1 2021 | $19,555,000 | -11.0% | 73,850 | -1.4% | 0.04% | -16.0% |
| Q4 2020 | $21,968,000 | +45.8% | 74,893 | +17.5% | 0.05% | +31.6% |
| Q3 2020 | $15,071,000 | +76.2% | 63,746 | +48.0% | 0.04% | +65.2% |
| Q2 2020 | $8,551,000 | +17.7% | 43,070 | +8.8% | 0.02% | -4.2% |
| Q1 2020 | $7,263,000 | +80.1% | 39,570 | +63.8% | 0.02% | +118.2% |
| Q4 2019 | $4,032,000 | – | 24,153 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 751,719 | $70,210,555 | 6.45% |
| Crabel Capital Management, LLC | 83,093 | $7,761 | 6.24% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,033,497 | $96,528,620 | 5.06% |
| Vazirani Asset Management LLC | 35,000 | $3,269,000 | 5.00% |
| Ergoteles LLC | 33,863 | $3,162,804 | 4.64% |
| Sand Grove Capital Management LLP | 282,850 | $26,418 | 3.29% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 162,973 | $15,221,678 | 2.48% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 80,923 | $7,558 | 2.44% |
| Melqart Asset Management (UK) Ltd | 350,328 | $32,720,635 | 2.34% |
| Westchester Capital Management, LLC | 850,386 | $79,426,052 | 2.32% |